Beryl Capital Management LLC
Long book
$108.6M
Q1 2026
Positions
8
Top-10 weight
100%
concentration
Last quarter
+5.6%
SPY +14.8%
Turnover
95%
of book per quarter
Strategy in plain words
auto-generated from filingsBeryl Capital Management LLC is a concentrated fundamental stock-picker, specialised in communications (100% of the long book), running a $108.6M US long book across 8 positions.
The portfolio is extremely concentrated — the top 10 positions are almost the whole book. Turnover is high — positions rotate quickly, so individual names matter less than the process. Current anchor positions: MASIMO CORP, TERNS PHARMACEUTICALS INC, GREAT LAKES DREDGE & DOCK CO, DAY ONE BIOPHARMACEUTICALS I, SUNOPTA INC.
Over the last 9 quarters its long book ran on average 2.9pp per quarter ahead of the S&P 500, beating the index in 4 of 9 quarters. We rate its filings as signal-bearing: position changes reflect genuine views.
Implied long-book return vs S&P 500
methodology: positions priced quarterly, no shorts/options Fund long book S&P 500
Q1 2024
+4.0%
Q2 2024
+19.3%
Q3 2024
+15.1%
Q4 2024
-39.9%
Q1 2025
+6.1%
Q2 2025
+78.2%
Q3 2025
-21.0%
Q4 2025
-0.7%
Q1 2026
+5.6%
Sector allocation
Other 93%
Communications 7%
Long book by quarter
What does Beryl Capital own?
Q1 2026 13F| Company | Sector | Shares | Value | % of book | Change |
|---|---|---|---|---|---|
| MASI* MASIMO CORP | — | 217.1K | $38.6M | 35.5% | New |
| 430 TERNS PHARMACEUTICALS INC | — | 478.8K | $25.2M | 23.2% | New |
| GLDD GREAT LAKES DREDGE & DOCK CO | — | 912.5K | $15.5M | 14.3% | New |
| DAWNGBX DAY ONE BIOPHARMACEUTICALS I | — | 514.1K | $11.0M | 10.1% | New |
| STKL SUNOPTA INC | — | 1.5M | $9.8M | 9.0% | New |
| WBD WARNER BROS DISCOVERY INC | Communications | 187.4K | $5.1M | 4.7% | +184.2% |
| ADEA ADEIA INC | Communications | 121.1K | $2.9M | 2.7% | New |
| FB1 FARMER BROS CO | — | 336.7K | $428K | 0.4% | New |
13F filing history
| Period | Form | Filed | Entries | Reported value | Flags | Source |
|---|---|---|---|---|---|---|
| Q1 2026 | 13F-HR | May 15, 2026 | 9 | $109.7M | canonical | SEC ↗ |
| Q4 2025 | 13F-HR | Feb 17, 2026 | 15 | $986.3M | canonical | SEC ↗ |
| Q3 2025 | 13F-HR | Nov 14, 2025 | 6 | $52.0M | canonical | SEC ↗ |
| Q2 2025 | 13F-HR | Aug 14, 2025 | 28 | $664.0M | canonical | SEC ↗ |
| Q1 2025 | 13F-HR | May 15, 2025 | 13 | $267.7M | canonical | SEC ↗ |
| Q4 2024 | 13F-HR | Feb 14, 2025 | 31 | $442.6M | canonical | SEC ↗ |
| Q3 2024 | 13F-HR | Nov 14, 2024 | 30 | $463.0M | canonical | SEC ↗ |
| Q2 2024 | 13F-HR | Aug 14, 2024 | 24 | $332.6M | canonical | SEC ↗ |
| Q1 2024 | 13F-HR | May 15, 2024 | 18 | $82.0M | canonical | SEC ↗ |